Related Experiment Video
Updated: Oct 10, 2026

Transplantation of Human Stem Cell-Derived GABAergic Neurons into the Early Postnatal Mouse Hippocampus to Mitigate Neurodevelopmental Disorders
Published on: November 11, 2022
Transplantation of human fetal striatal tissue in Huntington's disease: rationale for clinical studies
T B Freeman1, R A Hauser, A E Willing
1Department of Neurosurgery, University of South Florida, 4 Columbia Drive, Suite 730, Tampa, FL 33606, USA.
Abstract:
Huntington's disease is a fatal neurological disorder characterized by chorea and deterioration in cognitive and neuropsychiatric function. Primary pathological changes are found in the striatum, where GABAergic neurons undergo degenerative changes. Local interneurons are relatively spared. Here, we describe the rationale for clinical trials of fetal striatal tissue transplantation for the treatment of Huntington's disease. Specifically, the reasons for utilizing tissue derived from the far lateral aspect of the lateral ventricular eminence as a source of striatal tissue will be discussed.

